Cargando…
Breast cancer prognosis is poor when total plasminogen activator activity is low.
Plasminogen activator (PA) is a serine protease which exists in two forms: tissue-type (t-PA) and urokinase-type (u-PA). The total PA activity was measured in tumour extracts of 235 breast cancer patients who were followed for a median of 8.5 years after surgery. Patients were initially divided into...
Autores principales: | Yamashita, J., Ogawa, M., Inada, K., Yamashita, S., Nakashima, Y., Saishoji, T., Nomura, K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968174/ https://www.ncbi.nlm.nih.gov/pubmed/8431369 |
Ejemplares similares
-
Differential biological significance of tissue-type and urokinase-type plasminogen activator in human breast cancer.
por: Yamashita, J., et al.
Publicado: (1993) -
Hormone control of total plasminogen activator activity is specific to malignant DMBA-induced rat mammary tumours.
por: Inada, K., et al.
Publicado: (1992) -
Production of immunoreactive polymorphonuclear leucocyte elastase in human breast cancer cells: possible role of polymorphonuclear leucocyte elastase in the progression of human breast cancer.
por: Yamashita, J. I., et al.
Publicado: (1994) -
Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
por: Tsai, Ming-Chao, et al.
Publicado: (2019) -
Unruptured Cerebral Aneurysm Detected after Intravenous Tissue Plasminogen Activator for Stroke
por: Yoneda, Yukihiro, et al.
Publicado: (2009)